Pharmaceutical manufacturers of Tacrolimus

TAPI stands as the primary global provider of active pharmaceutical ingredients (APIs). With the most extensive range of over 370 high-caliber API products in the industry, we cater to almost 1,000 clients across more than 100 nations. Operating as an independent division under Teva Pharmaceutical Industries, our legacy in the generic API sector spans over 80 years. Situated in close proximity to Tel Aviv, Israel, TAPI boasts a workforce of over 5,000 professionals spread across 19 facilities worldwide. Our cutting-edge manufacturing plants are situated in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, and several other locations.

CKD Bio Corporation focuses on enhancing life through improved pharmaceuticals, drawing from a wealth of 80 years' experience in the industry. The company specializes in the production of top-quality intermediates and APIs, employing a comprehensive manufacturing process that encompasses fermentation and chemical synthesis

Founded in 1956, Zhejiang Hisun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise featuring whole chain, multi-regional integration of research, production and marketing as well as development of drug substances and preparations. In 2000, an A-share was issued in order to enter the stock market as a state-owned listed company. As of 2021, Hisun Pharmaceutical is now one of the largest producers of antibiotics and anti-tumor drugs in China and has been listed in the Top 500 Chinese manufacturing enterprises and the Top 100 Chinese pharmaceutical enterprises multiple times. In 2020 Hisun Pharmaceuticals received special recognition from the Joint Prevention and Control Team from the State Council of the People’s Republic of China for their extraordinary efforts in the fight against the epidemic, and Hisun Pharmaceutical was awarded with the “Anti COVID-19 Advanced Collective in Ministry of Industry and Information Technology".

Founded in 1978, Biocon Limited is the largest biotechnology company in India and a leading company in Asia, focusing on biopharmaceuticals and research services. It is an integrated and innovation-driven enterprise that provides affordable solutions for chronic diseases globally. The company develops, manufactures, and offers a diverse portfolio of Small Molecules APIs & Formulations and Complex Biologics, including Novels and Biosimilars like MAbs, rh-insulin& Insulin Analogs. Among its notable products are the world's first Pichia-based recombinant human Insulin, INSUGEN, Glargine, BASALOG, and India's first biologic BioMAb-EGFR for head and neck cancer. Additionally, it has developed Itolizumab, a 'first in class' anti-CD6 monoclonal antibody, introduced as Alzumab for psoriasis in India in 2013.

For more than 40 years, Apotex has been a reputable name in the Canadian pharmaceutical industry, offering patients increased availability to high-quality, cost-effective medications

Greetings, we are Sandoz B2B. As a division of Sandoz, we are completely dedicated to ensuring availability of cost-effective medication for everyone. We distribute high-quality medication globally through close collaboration with pharmaceutical partners. Whether it involves active pharmaceutical ingredients, finished dosage products, or comprehensive end-to-end CDMO solutions, we are here for you.

NCPC International Corp. is a platform for international trade of NCPC and the exclusive channel for exporting the preparations of NCPC, the business scope covers import and export trade, CMO, technology transfer and pharmaceutical logistics in domestic. NCPC International Corp. provides all-around and one-stop sales and service on APIs, preparations, medical equipments and consumables, based on creating more values for foreign customers. NCPC International Corp. has been exporting to more than 80 countries and regions, increasing the overseas sales yearly, ranking 1st on exporting preparations in china mainland for last continuous 3 years. NCPC International Corp. is a worldwide supplier of generic pharmaceuticals. As an Anti-infective expert and your local one- stop partner NCPC International Corp. will provide you the most comprehensive products and the most professional and efficient services. We are sincerely expecting to cooperate with friends from all sectors for shared development and a brighter future!

BrightGene Bio-Medical Technology Co., Ltd (stock code: 688166) is an innovative pharmaceutical enterprise participating in international competition. Relying on R&D drive, the company focuses on the first imitation, difficult imitation, characteristic APIs, complex preparations and original new drugs, continues to create high-tech barriers, gradually establishes a business system that integrates APIs and preparations, combines generic drugs with innovative drugs, and pays equal attention to the international market and domestic market, and is committed to meeting the unmet clinical needs of patients worldwide.

Astellas Pharma Inc. is dedicated to realizing its corporate mission of enhancing global health by developing and delivering innovative and dependable pharmaceutical products. The company is committed to supporting patients worldwide by continually producing groundbreaking and highly effective medications for diseases with significant unmet medical needs through its research and development endeavors.

Lunan Pharma is a prominent pharmaceutical firm dedicated to enhancing human well-being through the production and promotion of top-quality pharmaceutical products. The company achieved total sales revenues of 1.8 billion dollars in 2020 and is ranked among the top 22 in China.

Haorui, established in the year 1997, operates as a manufacturer and provider of APIs, pharmaceutical intermediates, veterinary products, and food additives. Furthermore, it aids international pharmaceutical firms in achieving domestic registration for their finished dosage forms to support their global expansion efforts. The company's array of USFDA approved products includes Flumazenil, Granisetron HCl, Granisetron Base, Docetaxel Anhydrous, Irinotecan HCl, and Dasatinib Monohydrate among others. Its headquarters is situated in Shenzhen, China, while it maintains four manufacturing sites in Hubei, Zhejiang, Jiangxi, and Henan. The Hubei facility is recognized for its USFDA and EU GMP approvals, specializing in the production of high potency and oncology materials within a dedicated oncology workshop, meeting OEB 5 material production standards. Haorui prides itself as a dependable partner for all your pharmaceutical needs.

Concord Biotech Limited is a prominent vertically integrated, research and development-driven biotechnological powerhouse that produces Active Pharmaceutical Ingredients using fermentation and semi-synthetic methods, as well as Finished formulations. Established in 2000, Concord has evolved from a single-product enterprise to a wide-ranging solution provider, offering products across varied therapeutic segments. Concord is internationally recognized for its products and holds a strong presence in over 50 countries worldwide with effective distribution infrastructure in markets such as North America, Europe, Japan, Central & Latin America, Africa, Australia, and other regions.

CCSB has developed more than 30 bulk pharmaceutical products including Anti-Anxiety agent, Antidiabetics, Laxatives, Antifungals, Antihistamines, Antiseptics, Antiulcerants, Cardiovascular drugs, Skeletal, Muscle relaxants, Hypolipaemics, Antineoplastic, Antihyperlipedemia and Immunosuppresant. In 1984, CCSB was the first pharmaceutical manufacturer in Taiwan inspected and approved by FDA for cGMP compliance. CCSB has filed DMF's for 19 products with the FDA.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

Established in 2004, Murli Krishna Pharma Pvt Ltd is a youthful and dynamic organization specializing in Novel Drug Delivery Systems (NDDS). It offers a variety of effective solutions for enhancing the delivery of pharmaceutical products. The current operations involve the production of pre-finished formulations such as Pellets, Granules, and MUPS using Aqueous Based technology, Nano Particles, and Transdermal Oil. The facility is furnished with state-of-the-art machinery and 21 CFR, part 11 compliant instruments.

Sarv Biolabs Pvt Ltd is a prominent manufacturer of high-quality Phytochemicals (Herbal Drugs and Extracts) / APIs, derived from Natural Herbs/Leaves/Seeds/Barks. Its diverse range of products includes Thiocolchicoside, Colchicine, Deacetyl Baccatine III (10-DAB III), Camptothecin, Reserpine, Raubasine, Hyoscine N-Butyl Bromide, Curcumin, and more. All items are manufactured under sanitary conditions in accordance with pharmacopoeias standards. The manufacturing facility for APIs is located in the foothills of the Himalayas and is equipped with state-of-the-art machinery. The company employs a variety of traditional and modern techniques and holds WHO GMP and ISO 9001:2008 certifications, following USFDA guidelines.